Impact of metastasectomy in disseminated renal cell carcinoma [Stellenwert der metastasen-chirurgie beim metastasierten nierenzellkarzinom]

被引:0
|
作者
Volkmer B.G. [1 ,2 ]
Gschwend J.E. [1 ]
机构
[1] Klin. fur Urologie/Kinderurologie, Urologischen Universitatsklinik Ulm, Ulm
[2] Urologische Universitatsklinik Ulm, 89075 Ulm
来源
Der Urologe A | 2002年 / 41卷 / 3期
关键词
Metastasectomy; Renal cell carcinoma;
D O I
10.1007/s00120-002-0204-4
中图分类号
学科分类号
摘要
Metastasectomy in patients with renal cell carcinoma has to be considered as a palliative approach for symptomatic metastases (e.g., pathologic fracture) or as a curative aproach in patients with the option for radical resection of all metastases. By modern perioperative management, even extended resections can be performed with limited morbidity and mortality. The survival rate is significantly higher after resection of pulmonary metastases than after resection of extrapulmonary metastases. Solitary metastases show a better prognosis than multiple metastases. Metachronous metastases that develop after a tumor-free interval of at least 12 months after tumor nephrectomy have a better prognosis than earlier metastases. For metastases that are resected with a curative intent, the best long-term results can be achieved after complete or radical resection.
引用
收藏
页码:225 / 230
页数:5
相关论文
共 50 条
  • [41] Charakterisierung der unterschiedlichen Entitäten beim NierenzellkarzinomCharacterization of different renal cell carcinoma entities
    N. J. Rupp
    H. Moch
    Der Urologe, 2020, 59 (2): : 135 - 141
  • [42] Wann ist die operative Versorgung von Metastasen beim Nierenzellkarzinom angezeigt und gibt es eine wissenschaftliche Grundlage hierfür?Is surgical treatment ever indicated in metastatic renal cell carcinoma and if so, based on which scientific rationale?
    M. Burger
    Der Urologe, 2017, 56 (5): : 617 - 623
  • [43] Transcriptome analyses in renal cell carcinoma. Combination of laser microdissection and microarrays [Transkriptomanalysen beim nierenzellkarzinom. Kombination von lasermikrodissektion und microarrays]
    Buchner A.
    Castro M.
    Hennig A.
    Popp T.
    Assmann G.
    Hofstetter A.
    Stief C.
    Zimmermann W.
    Der Urologe, 2007, 46 (9): : 1170 - 1175
  • [44] The Impact of Metastasectomy on Survival Outcomes of Renal Cell Carcinoma: A 10-Year Single Center Experience
    Ferriero, Mariaconsiglia
    Cacciatore, Loris
    Ochoa, Mario
    Mastroianni, Riccardo
    Tuderti, Gabriele
    Costantini, Manuela
    Anceschi, Umberto
    Misuraca, Leonardo
    Brassetti, Aldo
    Guaglianone, Salvatore
    Bove, Alfredo Maria
    Papalia, Rocco
    Gallucci, Michele
    Simone, Giuseppe
    CANCERS, 2023, 15 (13)
  • [45] Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry
    Meagher, Margaret F.
    Mir, Maria C.
    Autorino, Riccardo
    Minervini, Andrea
    Kriegmair, Maximilian
    Maurer, Tobias
    Porpiglia, Francesco
    Van Bruwaene, Siska
    Linares, Estefania
    Hevia, Vital
    Musquera, Mireia
    Roussel, Eduard
    Pavan, Nicola
    Antonelli, Alessandro
    Zhang, Shudong
    Ghali, Fady
    Patel, Devin
    Javier-Desloges, Juan
    Bradshaw, Aaron
    Rubio, Jose
    Guruli, Georgi
    Tracey, Andrew
    Campi, Riccardo
    Albersen, Maarten
    Furlan, Maria
    McKay, Rana R.
    Derweesh, Ithaar H.
    CLINICAL GENITOURINARY CANCER, 2022, 20 (04) : 326 - 333
  • [46] THE IMPACT OF METASTASECTOMY ON SURVIVAL OUTCOMES OF RENAL CELL CARCINOMA: A 10-YEAR SINGLE CENTER EXPERIENCE
    Ferriero, Mariaconsiglia
    Costantini, Manuela
    Mastroianni, Riccardo
    Tuderti, Gabriele
    Anceschi, Umberto
    Brassetti, Aldo
    Bove, Alfredo Maria
    Misuraca, Leonardo
    Iannuzzi, Andrea
    Guaglianone, Salvatore
    Gallucci, Michele
    Simone, Giuseppe
    JOURNAL OF UROLOGY, 2023, 209 : E370 - E371
  • [47] Impact of metastasectomy on progression free and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry
    Meagher, Margaret Frances
    Autorino, Ricardo
    Kriegmair, Maximilian
    Mir, Maria Carmen
    Rubio, Jose
    Campi, Riccardo
    Mari, Andrea
    Heck, Matthias
    Porpiglia, Francesco
    Van Bruwaene, Siska
    Espinos, Estefania Linares
    Musquera, Mireia
    Ghali, Fadi
    Veccia, Alessandro
    Guruli, Georgi
    Rousel, Eduard
    Pavan, Nicola
    Antonelli, Alessandro
    Marchioni, Michele
    Derweesh, Ithaar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [48] Renal cell carcinoma. Immunohistological study to the expression of the inactive form of the pyruvatekinase [Nierenzellkarzinom: Immunhistologische untersuchungen zur expression der inaktiven form der pyruvatkinase]
    Wechsel H.W.
    Petri E.
    Feil G.
    Neide H.-J.
    Bichler K.-H.
    Der Urologe A, 1999, 38 (6): : 583 - 585
  • [49] A Retrospective Analysis of the Impact of Metastasectomy on Prognostic Survival According to Metastatic Organs in Patients With Metastatic Renal Cell Carcinoma
    Kim, Sung Han
    Park, Weon Seo
    Park, Boram
    Pak, Sahyun
    Chung, Jinsoo
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [50] Das FH-defiziente Nierenzellkarzinom erweitert das Spektrum der papillären Tumoren in der NiereFH-deficient renal cell carcinoma expands the spectrum of renal papillary tumors
    N. Rupp
    H. Moch
    Der Pathologe, 2021, 42 (6): : 560 - 564